RSV

Pfizer (PFE) or GSK: Who Will Get the First FDA Nod for RSV Jab?
Yahoo/Zacks.com
Wed, 03/8/23 - 09:30 am
GSK
Pfizer
FDA
vaccines
RSV
FDA advisors recommend GSK’s RSV vaccine for older adults, but flag potential safety risks
CNBC
Wed, 03/1/23 - 06:56 pm
GSK
RSV
vaccines
FDA
Pfizer's RSV vaccine wins support of FDA panel despite lingering safety and efficacy questions
Fierce Biotech
Tue, 02/28/23 - 10:56 pm
Pfizer
RSV
vaccines
Abrysvo
FDA
Go or no go? Vaccines and neurology up for discussion
EP Vantage
Tue, 02/28/23 - 11:05 am
FDA
Acadia Pharmaceuticals
Apellis Pharmaceuticals
AstraZeneca
Biogen
Biomarin
Cidara Therapeutics
Emergent BioSolutions
GSK
Incyte
Ionis Pharmaceuticals
Melinta Therapeutics
Mundipharma
Novartis
Pfizer
Pharming
Regeneron
Roche
vaccines
RSV
ALS
COVID-19
Icosavax receives fast track designation for IVX-A12 vaccine candidate
Pharmaceutical Business Review
Wed, 02/22/23 - 09:54 am
Icosavax
IVX-A12
vaccines
RSV
hMPV
Pfizer's maternal RSV vaccine filing gets priority review, setting up showdown with AstraZeneca, Sanofi
Fierce Pharma
Tue, 02/21/23 - 10:26 am
Pfizer
RSV
vaccines
GSK
AstraZeneca
Sanofi
RSVpreF
Spybiotech seeks new vaccines
EP Vantage
Tue, 02/21/23 - 10:06 am
vaccines
Oxford University
Spybiotech
RSV
First FDA-Approved RSV Vaccines Expected Later This Year: The Top Vaccines And Their Effectiveness
Forbes
Mon, 02/20/23 - 12:37 pm
RSV
vaccines
GSK
Pfizer
Sanofi
Sobi
Moderna Therapeutics
AstraZeneca
JNJ
FDA
GSK vaccine R&D head touts consistency of RSV data but is mum on restarting maternal trial
Fierce Biotech
Thu, 02/16/23 - 10:16 am
GSK
R&D
RSV
vaccines
FDA
FDA to convene advisers on review of RSV vaccines from GSK, Pfizer
BioPharma Dive
Wed, 02/1/23 - 10:16 pm
GSK
Pfizer
RSV
vaccines
Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate
BioSpace
Mon, 01/30/23 - 10:37 am
Moderna Therapeutics
FDA
mRNA-1345
vaccines
RSV
breakthrough therapy
Sanofi takes to TikTok and Instagram to target millennials and older Gen Z parents for RSV education
Endpoints
Wed, 01/25/23 - 10:51 pm
Sanofi
social media
TikTok
Instagram
RSV
pharma marketing
Moderna Gets Good News, but Another Biotech Stock Is Falling Again
Motley Fool
Wed, 01/18/23 - 09:50 am
Moderna Therapeutics
RSV
Bluebird Bio
NASDAQ
Playing catch-up to Big Pharma, Moderna posts come-from-behind RSV data
Fierce Biotech
Tue, 01/17/23 - 10:52 pm
Moderna Therapeutics
RSV
vaccines
GSK
Pfizer
FDA starts review of Sanofi, AZ antibody for RSV prevention
Pharmaphorum
Thu, 01/5/23 - 10:20 am
RSV
Sanofi
AstraZeneca
FDA
antibodies
nirsevimab
Moderna sprints toward RSV podium behind GSK, Pfizer, with eyes on combo vax
Fierce Biotech
Thu, 01/5/23 - 10:14 am
Moderna Therapeutics
RSV
GSK
Pfizer
vaccines
Pfizer's RSV vaccine rush gets FDA boost with priority review
Fierce Biotech
Wed, 12/7/22 - 11:45 pm
Pfizer
RSV
vaccines
FDA
priority review
RSVpreF
Pediatric health groups call for national emergency to fight respiratory illnesses
The Hill
Fri, 11/18/22 - 10:30 am
pediatrics
physicians
Joe Biden
RSV
COVID-19
Flu
Blue Lake reports positive data from Phase I RSV vaccine trial
Clinical Trials Arena
Tue, 11/8/22 - 11:08 am
Blue Lake Biotechnology
clinical trials
vaccines
BLB201
RSV
Sanofi, AstraZeneca clinch first OK for RSV antibody — just as vaccines line up at regulators
Endpoints
Fri, 11/4/22 - 10:21 am
Sanofi
AstraZeneca
RSV
nirsevimab
Europe
vaccines

Pages